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Rationale
Hypernatremia is associated with increased incidences of 
morbidity and mortality across heterogeneous populations, 
including intensive care units (ICUs), general wards, and 
outpatient settings.1–9 While less than 10% of patients are 
hypernatremic upon admission (“community-acquired” 
hypernatremia), up to 26% of medical ICU patients and 10% 
of surgical ICU patients become hypernatremic during their 
stay in the ICU,10,11 including as many as half of critically ill 
patients with sepsis.12 Hospital-acquired hypernatremia 
(HAH), specifically hypernatremia that develops in the ICU, 
is associated with increased risk of death with reported crude 
in-hospital mortality rates ranging from 14% to 48%.10 
Morbid outcome associations include prolonged hospital and 
ICU stay as well as need for dialysis/renal replacement ther-
apy.13 Similar findings have been reported in the pre- and 
postsurgical setting.14–16 Some authors have suggested that 
incident hypernatremia be used as a quality metric of appro-
priate care.17–20
Hypervolemic hypernatremia after resuscitation is now 
common in ICUs and on medical wards accounting for about 
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Background: Healthcare-acquired hypernatremia (serum sodium >145 mEq/dL) is common among critically ill and other 
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half of HAH cases in some reports.21–24 One study showed 
that nearly half of ICU patients with sepsis developed hyper-
natremia.12 Published literature generally recommends a 
similar therapeutic strategy to treat community-acquired 
hypernatremia (CAH) and HAH: correcting a free water def-
icit with solute-poor/solute-free fluid. Some sources recom-
mend diuretics along with free water replacement in 
hypervolemic HAH out of a belief that excess iatrogenic 
sodium loading may contribute to the hypernatremia.1,5–8 
Fluids administered for this purpose are “discretionary flu-
ids” and contribute positively to the patient’s net fluid 
balance.25
Accumulating evidence suggests that a positive fluid bal-
ance after the initial resuscitation phase worsens outcomes in 
critically ill patients.26–28 This creates a clinical dilemma 
regarding how best to therapeutically approach volume sta-
tus in hypernatremic resuscitated patients. Because expert 
recommendations appear generally to assume a hypovolemic 
hypernatremic state (as commonly occurs in CAH) and 
because we were personally unaware of any controlled rand-
omized or observational cohort studies designed to measure 
the impact of any therapeutic action intended to correct HAH 
on clinically relevant outcomes among otherwise-similar 
patients or in animal models, we undertook a structured lit-
erature search to identify any studies providing evidence 
assessing therapeutic interventions to correct hypernatremia 
in resuscitated adult patients with sepsis or other forms of 
shock.
Objectives
We searched for any randomized- or observational-con-
trolled trials evaluating the impact of active correction of 
hypernatremia to eunatremia on any outcomes in adult 
patients with shock or sepsis that have been adequately 
resuscitated as assessed by the treating or the research team.
Eligibility criteria
Studies were identified by searching electronic databases 
(K.S.) and scanning the reference lists of relevant articles 
(D.E.S. and J.W.Q.). No date limits were applied to the 
search, but we restricted studies to English language due to 
time and resource constraints (funding for and availability of 
translation services). The search was adapted from some of 
the search domains used in the searches constructed for the 
NICE guidelines on Intravenous fluid therapy in adults in 
hospital as appropriate. The search was constructed by the 
librarian and search terms were reviewed and agreed upon 
by authors prior to application within the databases.
Information sources
The search was initially constructed, tested, and conducted 
in MEDLINE (PubMed, 1946 to present) and adapted for 
Embase (1947 to present), Cochrane Central Register of 
Controlled Trials (1991 to present), Cochrane Database of 
Systematic Reviews (2005 to present), DARE (Database 
of Reviews of Effects, 1991–2015), ClinicalTrials.gov 
(2000 to present), and CINAHL (1937 to present), with the 
index terms being mapped to non-MEDLINE equivalents, 
as necessary. Additionally, the Index-Catalogue of the 
Library of the Surgeon General’s Office was searched 
without date limits. The search was applied until 11 
February 2017.
Search strategy
1. Dysnatremias search domain
A. “Hyponatremia” [MeSH]
B. “Hypernatremia” [MeSH]
C. hyponatremia[tiab] OR hypernatremia[tiab] OR 
dysnatremia[tiab] OR hyponatraemia[tiab] OR 
hypernatraemia[tiab] OR dysnatraemia[tiab] OR 
hypernatremias[tiab] OR hyponatremias[tiab] OR 
dysnatremias[tiab] OR hypernatraemias[tiab] OR 
hyponatraemias[tiab] OR dysnatraemias[tiab] OR 
“sodium imbalance”[tiab] OR “sodium imbalances” 
[tiab]
D. 1A OR 1B OR 1C
2. Fluid therapy search domain
A. “time factors”[mh]
B. (rapid[tiab] OR fast[tiab] OR slow[tiab] OR 
slowness[tiab] OR slowly[tiab]) AND
C. (infuse[tiab] OR infuses[tiab] OR infusion[tiab] 
OR infusions[tiab] OR administration[tiab] OR 
administrate[tiab] OR administrates[tiab] OR 
administrations[tiab] OR fluid[tiab] OR fluids[tiab] 
OR volume[tiab])
D. 2B AND 2C
E. (small[tiab] OR large[tiab] OR high[tiab] OR 
low[tiab])
F. (infuse[tiab] OR infuses[tiab] OR infusion[tiab] 
OR infusions[tiab] OR administration[tiab] OR 
administrate[tiab] OR administrates[tiab] OR 
administrations[tiab] OR fluid[tiab] OR fluids[tiab] 
OR volume[tiab])
G. 2E AND 2F
H. (restrict[tiab] OR restriction[tiab] OR restrictive 
[tiab] OR restrictions[tiab] OR restrictively[tiab] 
OR conservative[tiab] OR conservatively[tiab] OR 
liberal[tiab] OR liberally[tiab])
I. (fluid[tiab] OR fluids[tiab] OR regime[tiab] OR 
regimes[tiab] OR regimen[tiab] OR regimens[tiab] 
OR regimentation[tiab] OR regimentations[tiab] OR 
protocol[tiab] OR protocols[tiab] OR intake 
[tiab] OR intakes[tiab])
J. 2H AND 2I
K. (timing[tiab] OR delayed[tiab] OR intermediate 
[tiab] OR early[tiab] OR selective[tiab] OR rapid[tiab] 
OR immediate[tiab] OR immediately[tiab])
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L. (fluid[tiab] OR fluids[tiab] OR therapy[tiab] OR 
therapies[tiab] OR intravenous[tiab] OR 
intravenously[tiab] OR iv[tiab])
M. 2K AND 2L
N. (fluid[tiab] OR fluids[tiab])
O. bolus[tiab])
P. 2N AND 2O
Q. 2A OR 2D OR 2G OR 2J OR 2M OR 2P
3. Shock, hypovolemia, and sepsis search domain
A. shock[mh] OR “Hypovolemia”[MeSH:noexp] OR 
hypotension[MeSH:noexp] OR dehydration[MeSH: 
noexp] OR “fluid therapy”[majr]
B. (fluid[tiab] OR fluids[tiab] OR volume[tiab] OR 
volumes[tiab] OR volumetric[tiab])
C. (restoration[tiab] OR restore[tiab] OR restores 
[tiab] OR restorations[tiab] OR resuscitation[tiab] 
OR resuscitations[tiab] OR resuscitate[tiab] OR 
resuscitative[tiab] OR replace[tiab] OR replaces 
[tiab] OR replacement[tiab] OR replacements[tiab] 
OR replacing[tiab] OR deplete[tiab] OR depletes 
[tiab] OR depleting[tiab] OR depletion[tiab] OR 
depletions[tiab] OR deficiency[tiab] OR 
deficient[tiab] OR deficiencies[tiab])
D. 3B AND 3C
E. (hypotension[tiab] OR hypotensive[tiab] OR 
hypotensions[tiab])
F. (resuscitation[tiab] OR resuscitations[tiab] OR 
resuscitate[tiab] OR resuscitative[tiab])
G. 3E AND 3F
H. (shock[tiab] OR resuscitation[tiab] OR 
resuscitations[tiab] OR resuscitate[tiab] OR 
resuscitative[tiab] OR hypotention[tiab] OR 
hypotensive[tiab] OR hypotensions[tiab] OR 
dehydrate[tiab] OR dehydration[tiab] OR 
dehydrates[tiab] OR dehydrations[tiab] OR 
dehydrating[tiab])
I. (fluid[tiab] OR fluids[tiab])
J. 3H AND 3I
K. (hypovolemia[tiab] OR hypovolaemia[tiab] OR 
hypovolemic[tiab] OR hypovolaemic[tiab] OR 
hypovolemics[tiab] OR hypovolaemics[tiab] OR 
“sepsis syndrome”[tiab] OR “sepsis syndromes” 
[tiab] OR “circulatory failure”[tiab] OR “circulatory 
failures”[tiab])
L. (circulatory[tiab] OR hemodynamic[tiab] OR 
haemodynamic[tiab])
M. (failure[tiab] OR failures[tiab] OR insufficiency 
[tiab] OR insufficiencies[tiab] OR insufficient 
[tiab] OR abnormality[tiab] OR abnormalities 
[tiab] OR instability[tiab] OR instabilities[tiab])
N. 3L AND 3M
O. (shock[tiab] OR resuscitation[tiab] OR 
resuscitations[tiab] OR resuscitate[tiab] OR 
resuscitative[tiab] OR hypotension[tiab] OR 
hypotensive[tiab] OR hypotensions[tiab] OR 
dehydrate[tiab] OR dehydration[tiab] OR 
dehydrates[tiab] OR dehydrations[tiab] OR 
dehydrating[tiab])
P. 3A OR 3D OR 3G OR 3J OR 3K OR 3N OR 30
4. Adult filter
A. Child[mh]
B. child[tiab] OR children[tiab] OR infant[tiab] OR 
infants[tiab] OR neonate[tiab] OR neonates[tiab] 
OR neonatal[tiab] OR newborn[tiab] OR 
newborns[tiab] OR boy[tiab] OR boys[tiab] OR 
girl[tiab] OR girls[tiab] OR adolescent[tiab] OR 
adolescents[tiab]
C. 4A OR 4B
D. Adult[mh]
E. adult[tiab] OR adults[tiab]
F. 4D OR 4F




C. 5A NOT 5B
6. Final search combination
((1D AND (2Q OR 3P)) NOT 4G) NOT 5C
Study records
Data management
After deduplication in RefWorks, citations were exported to 
Microsoft Excel (Microsoft Corporation, Redmond, WA, 
USA) in a spreadsheet format. This file was then duplicated 
and given to both reviewers (J.W.Q. and D.E.S.) to work 
independently and to avoid potential bias.
Selection process
After deduplication, 3746 article abstracts were identified 
and individually reviewed to determine whether any con-
trolled trials supporting correction to eunatremia in the for-
merly described search criteria were present. As the 
spreadsheet had been duplicated, the reviewers were not 
aware of the other’s review. There was no disagreement in 
the final conclusion, so no consensus was needed for resolu-
tion of inclusion decisions (Figure 1).
Data collection process
No randomized or observational-controlled studies were 
identified that assessed the impact of any active therapeutic 
maneuver intended to correct serum sodium concentrations 
on any outcome in resuscitated adult patients with resolving 
sepsis or other shock. Less exhaustive supplementary 
searches failed to identify similar supporting literature 
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among pediatric, general hospitalized in-patient, or animal 
populations. We identified two small randomized studies 
evaluating the effectiveness of diuretics in manipulating 
sodium concentrations in critically ill patients, but these 
studies targeted a normonatremic population and were not 
intended to assess clinically important outcomes.29,30
Discussion
Our systematic review did not identify a single controlled 
study evaluating the impact of any active measure intended 
to correct hypernatremia in resuscitated patients with sepsis 
or other forms of shock on any clinically relevant endpoints. 
Although not the primary focus of our search, we also failed 
to identify any study demonstrating that free water or hypo-
tonic fluid administration effectively reduces serum sodium 
concentrations in this setting.
The association between hypernatremia and increased 
morbidity and mortality is well established in critically ill 
patients.1,5–8 However, evidence to establish the extent to 
which this association reflects causal mediation versus con-
founding is limited. Recent analyses suggest that existing 
prediction formulas cannot accurately predict changes in 
serum sodium in hyponatremic31 or hypernatremic32 in-
patients and that hypernatremia in critically ill patients is not 
adequately explained by excess sodium administration or a 
water deficit.33 One reasonable alternative hypothesis is that 
hypernatremia is primarily a marker of severe illness in 
resuscitated critically ill patients rather than a direct cause of 
poor outcomes. The recent observation that fluctuations in 
serum sodium concentrations even within a normal range 
carries increased risk of death34 suggests that absolute serum 
sodium concentration may be less important than the loss of 
homeostatic regulation that results in hypernatremia and 
supports such a hypothesis.
Accumulating evidence challenges the traditional equili-
bration model of sodium balance whose assumptions under-
lie accepted treatment strategies for hypernatremia.35 Skin, 
skeletal muscle, bone, and cartilage are known to act as res-
ervoirs of sodium.35–38 These reservoirs do not always equili-
brate with water and are not controlled by the kidney39 and 
may be more rapidly mobilized than previously recognized.40 
Additional evidence indicates that sodium is intimately tied 
to immune function and regulation, including inflammation 
and infection41,42 leading some authors to theorize that a 
hypertonic environment may serve as a host defense.42 The 
interplay of these systems during metabolically stressful 
events provides a mechanism by which sepsis and other 
forms of shock might result in an “intrinsic” form of hyper-
natremia independent of volume status.
Given the demonstrated morbidity associated with hyper-
volemia in critically ill patients,27,43–45 the established benefits 
of “deresuscitation” in such patients,43,46 and the absence of 
evidence of improved outcomes with volume administration 
to treat hypernatremia in resuscitated patients, we believe that 
a cautiously “salt-tolerant/fluid-restricted” therapeutic strat-
egy is at least as well supported by existing research as is the 
dominant “salt-intolerant/fluid-liberal” paradigm.
There are limitations to our research. Our search required 
at least the search terms and the abstract be available in 
English. In addition, we may have overlooked gray literature 
on the topic such as doctoral dissertations or conference 
Figure 1. PRISMA flow diagram of systematic review.
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proceedings that were not published as supplements to medi-
cal journals.
Conclusion
We did not identify any randomized or observational-con-
trolled trials evaluating the use of active measures to correct 
hypernatremia in resuscitated patients recovering from criti-
cal illness. It is apparent that the existing body of scientific 
knowledge pertaining to sodium metabolism and homeosta-
sis in critically ill patients is distressingly sparse and is inad-
equate to meaningfully inform therapeutic decisions. 
Additional animal and clinical data are needed to empirically 
establish (1) the mechanisms driving hypernatremia in criti-
cally ill patients, (2) appropriate indications for therapeutic 
correction of hypernatremia following resuscitation, and (3) 
effective therapeutic strategies for improving clinically 
important outcomes in hypernatremic resuscitated critically 
ill patients.
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